Your browser doesn't support javascript.
loading
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells.
Ferrari, Samuele; Jacob, Aurelien; Cesana, Daniela; Laugel, Marianne; Beretta, Stefano; Varesi, Angelica; Unali, Giulia; Conti, Anastasia; Canarutto, Daniele; Albano, Luisa; Calabria, Andrea; Vavassori, Valentina; Cipriani, Carlo; Castiello, Maria Carmina; Esposito, Simona; Brombin, Chiara; Cugnata, Federica; Adjali, Oumeya; Ayuso, Eduard; Merelli, Ivan; Villa, Anna; Di Micco, Raffaella; Kajaste-Rudnitski, Anna; Montini, Eugenio; Penaud-Budloo, Magalie; Naldini, Luigi.
Affiliation
  • Ferrari S; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; Vita-Salute San Raffaele University, Milan 20132, Italy.
  • Jacob A; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Cesana D; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Laugel M; INSERM UMR 1089, University of Nantes, CHU of Nantes, Nantes 44200, France.
  • Beretta S; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Varesi A; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Unali G; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Conti A; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Canarutto D; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; Vita-Salute San Raffaele University, Milan 20132, Italy; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Albano L; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Calabria A; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Vavassori V; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Cipriani C; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Castiello MC; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; Institute for Genetic and Biomedical Research (UOS Milan Unit), National Research Council, Milan 20132, Italy.
  • Esposito S; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Brombin C; University Center for Statistics in the Biomedical Sciences, Vita-Salute San Raffaele University, Milan 20132, Italy.
  • Cugnata F; University Center for Statistics in the Biomedical Sciences, Vita-Salute San Raffaele University, Milan 20132, Italy.
  • Adjali O; INSERM UMR 1089, University of Nantes, CHU of Nantes, Nantes 44200, France.
  • Ayuso E; INSERM UMR 1089, University of Nantes, CHU of Nantes, Nantes 44200, France.
  • Merelli I; Institute for Biomedical Technologies, National Research Council, Segrate 20090, Italy.
  • Villa A; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; Institute for Genetic and Biomedical Research (UOS Milan Unit), National Research Council, Milan 20132, Italy.
  • Di Micco R; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Kajaste-Rudnitski A; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Montini E; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
  • Penaud-Budloo M; INSERM UMR 1089, University of Nantes, CHU of Nantes, Nantes 44200, France.
  • Naldini L; San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; Vita-Salute San Raffaele University, Milan 20132, Italy. Electronic address: naldini.luigi@hsr.it.
Cell Stem Cell ; 29(10): 1428-1444.e9, 2022 10 06.
Article in En | MEDLINE | ID: mdl-36206730
ABSTRACT
Long-range gene editing by homology-directed repair (HDR) in hematopoietic stem/progenitor cells (HSPCs) often relies on viral transduction with recombinant adeno-associated viral vector (AAV) for template delivery. Here, we uncover unexpected load and prolonged persistence of AAV genomes and their fragments, which trigger sustained p53-mediated DNA damage response (DDR) upon recruiting the MRE11-RAD50-NBS1 (MRN) complex on the AAV inverted terminal repeats (ITRs). Accrual of viral DNA in cell-cycle-arrested HSPCs led to its frequent integration, predominantly in the form of transcriptionally competent ITRs, at nuclease on- and off-target sites. Optimized delivery of integrase-defective lentiviral vector (IDLV) induced lower DNA load and less persistent DDR, improving clonogenic capacity and editing efficiency in long-term repopulating HSPCs. Because insertions of viral DNA fragments are less frequent with IDLV, its choice for template delivery mitigates the adverse impact and genotoxic burden of HDR editing and should facilitate its clinical translation in HSPC gene therapy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Viral / Tumor Suppressor Protein p53 Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cell Stem Cell Year: 2022 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Viral / Tumor Suppressor Protein p53 Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cell Stem Cell Year: 2022 Type: Article Affiliation country: Italy